Stock Valuation / HIMS

Is Hims & Hers Health, Inc. (HIMS) Overvalued? Fair Value & 5-Year Target

Hims & Hers Health, Inc. trades at $29.71 (P/E -47.16). Our reference model estimates a fair value of — at its recent average P/E of -13.62.

What drives HIMS's valuation

Changing either assumption moves the target: a higher P/E multiple or faster EPS growth raises fair value, a lower multiple or slower growth lowers it. The interactive dashboard lets you edit both and re-run the model instantly.

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair ca

Frequently asked questions

How do I value Hims & Hers Health, Inc. (HIMS)?

The Stock Valuation Dashboard lets you combine HIMS's current EPS and P/E with your own growth assumptions to estimate fair value and a 5-year price target.

Open the interactive HIMS valuation dashboard →

Figures are for informational purposes only and are not investment advice. Data as of 2026-10-14.